Award

Purchase of ANMI PSMA SETRILE 360 VIALS and ANMI ELUTION TOOLS GEN A

THE ROYAL MARSDEN NHS FOUNDATION TRUSTS

This public procurement record has 1 release in its history.

Award

31 May 2019 at 13:10

Award Notice
Summary of the contracting process

The Royal Marsden NHS Foundation Trusts is conducting a procurement process for the purchase of ANMI PSMA Setrile 360 vials and ANMI Elution Tools Gen A, specifically aimed at treating prostate cancer. This procurement is classified under the industry category of reagents and contrast media, with a total contract value of £2,000,000. The procurement method utilised is classified as 'Other', and the contract period will commence on 1st June 2019 and runs until 30th May 2021. The tender period closed on 26th May 2019, and the contract is primarily set to be delivered in London, United Kingdom.

This tender represents a significant opportunity for businesses specialising in medical supplies, pharmaceuticals, and imaging technologies, particularly those with capabilities in radiopharmaceutical production and distribution. Companies that can provide high-quality reagents and meet the specific requirements of the NHS, particularly in relation to prostate cancer diagnostics, would be well-positioned to compete. The active engagement of a reputable buyer like The Royal Marsden NHS Foundation Trusts further enhances the potential for business growth in this niche market.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Purchase of ANMI PSMA SETRILE 360 VIALS and ANMI ELUTION TOOLS GEN A

Notice Description

The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer in UK PMSA-11 is the most specific peptide-chelator available for diagnosis of prostate cancer. No other available treatment as effective are available on the NHS - Ga-68 PSMA scan can be used in PET imaging. PET imaging provides greater resolution and speed of imaging and therefore diagnosis of prostate cancer. PSMA (Prostate Specific Membrane Antigens) are over expressed on Prostate Tumours and therefore, by targeting and Imaging them with Radiopharmaceutical compounds, enables clinicians to better diagnose and manage patient's recurrent prostate cancer disease. There is currently no Marketing Authorisation for this product. The HBEDCC-11 kit Peptide, from ANMI, is the most widely available and popular choice at this time, that efficiently labels with Ga68 and provides high quality and accurate diagnosis of Prostate PSMA. The Royal Marsden Radiopharmacy already operates an efficient Ga68 Generator and therefore, is capable of combining with this HBEDCC-11 peptide from ANMI. Use of Ga-68 generator enables production of Ga-68 PSMA on-site allowing flexibility of service and negates reliance on outsourced companies for delivery radiopharmaceuticlals Curium is the official UK Distributor of the ANMI HBEDCC-11 PSMA Kit and follows the Regulated Import Pathway approved by the MHRA for this product.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/2799a347-dbb9-4d51-884f-1b85f00895c5
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Other -
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33696000 - Reagents and contrast media

Notice Value(s)

Tender Value
£2,000,000 £1M-£10M
Lots Value
Not specified
Awards Value
£2,200,000 £1M-£10M
Contracts Value
Not specified

Notice Dates

Publication Date
31 May 20196 years ago
Submission Deadline
26 May 2019Expired
Future Notice Date
Not specified
Award Date
30 May 20196 years ago
Contract Period
31 May 2019 - 30 May 2021 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
THE ROYAL MARSDEN NHS FOUNDATION TRUSTS
Contact Name
Not specified
Contact Email
tenders@chelwest.nhs.uk
Contact Phone
Not specified

Buyer Location

Locality
LONDON
Postcode
SW10 0XD
Post Town
South West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI33 Kensington & Chelsea and Hammersmith & Fulham
Delivery Location
TLI London
Local Authority
Hammersmith and Fulham
Electoral Ward
Sands End
Westminster Constituency
Chelsea and Fulham

Supplier Information

Number of Suppliers
1
Supplier Name

CURIUM PHARMA

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559-2019-05-31T14:10:32+01:00",
    "date": "2019-05-31T14:10:32+01:00",
    "ocid": "ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "CHELWEST-DN403487-13862453",
        "title": "Purchase of ANMI PSMA SETRILE 360 VIALS and ANMI ELUTION TOOLS GEN A",
        "description": "The Royal Marsden Hospital requires purchase of ANMI PSMA Setrile 360 VIALS and ANMI Elution Tools Gen A to treat prostate cancer. ANMI PSMA Setrile 360 Vials and ANMI Elution Tools Gen A is the only viable kit for imaging of prostate cancer in UK PMSA-11 is the most specific peptide-chelator available for diagnosis of prostate cancer. No other available treatment as effective are available on the NHS - Ga-68 PSMA scan can be used in PET imaging. PET imaging provides greater resolution and speed of imaging and therefore diagnosis of prostate cancer. PSMA (Prostate Specific Membrane Antigens) are over expressed on Prostate Tumours and therefore, by targeting and Imaging them with Radiopharmaceutical compounds, enables clinicians to better diagnose and manage patient's recurrent prostate cancer disease. There is currently no Marketing Authorisation for this product. The HBEDCC-11 kit Peptide, from ANMI, is the most widely available and popular choice at this time, that efficiently labels with Ga68 and provides high quality and accurate diagnosis of Prostate PSMA. The Royal Marsden Radiopharmacy already operates an efficient Ga68 Generator and therefore, is capable of combining with this HBEDCC-11 peptide from ANMI. Use of Ga-68 generator enables production of Ga-68 PSMA on-site allowing flexibility of service and negates reliance on outsourced companies for delivery radiopharmaceuticlals Curium is the official UK Distributor of the ANMI HBEDCC-11 PSMA Kit and follows the Regulated Import Pathway approved by the MHRA for this product.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33696000",
            "description": "Reagents and contrast media"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "London",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "minValue": {
            "amount": 1500000,
            "currency": "GBP"
        },
        "value": {
            "amount": 2000000,
            "currency": "GBP"
        },
        "procurementMethodDetails": "Other -",
        "tenderPeriod": {
            "endDate": "2019-05-26T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2019-06-01T00:00:00+01:00",
            "endDate": "2021-05-30T23:59:59+01:00"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-CFS-66778",
            "name": "The Royal Marsden NHS Foundation Trusts",
            "identifier": {
                "legalName": "The Royal Marsden NHS Foundation Trusts"
            },
            "address": {
                "streetAddress": "Unit G3, Harbour Yard, Chelsea Harbour",
                "locality": "London",
                "postalCode": "SW10 0XD",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "tenders@chelwest.nhs.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-116883",
            "name": "Curium Pharma UK Ltd,",
            "identifier": {
                "legalName": "Curium Pharma UK Ltd,"
            },
            "address": {
                "streetAddress": "Suite G30, Regus, 1000 Lakeside, Western Road, Portsmouth, Hampshire, United Kingdom PO6 3EZ"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-66778",
        "name": "The Royal Marsden NHS Foundation Trusts"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-4fa1a8db-4ab1-4a10-84b9-eafe6c5ae559-1",
            "status": "active",
            "date": "2019-05-31T00:00:00+01:00",
            "datePublished": "2019-05-31T14:10:32+01:00",
            "value": {
                "amount": 2200000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-116883",
                    "name": "Curium Pharma UK Ltd,"
                }
            ],
            "contractPeriod": {
                "startDate": "2019-06-01T00:00:00+01:00",
                "endDate": "2021-05-30T23:59:59+01:00"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/2799a347-dbb9-4d51-884f-1b85f00895c5",
                    "datePublished": "2019-05-31T14:10:32+01:00",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}